AbbVie (ABBV) declined in its latest intraday trading, as negative signals appeared on the RSI after reaching overbought levels. Despite this pullback, the stock remains above the key resistance level of 216.65, confirming its breakout and leaving room for further gains. Continued support from trading above the 50-day SMA and the prevailing short-term uptrend reinforce the bullish outlook.

Therefore, we expect the stock to rise in upcoming sessions, as long as it holds above 216.65, targeting the next resistance at 233.40.

Todays price forecast: Bullish.